The discovery of objective biomarkers for diagnostic and therapeutic purposes is the subject of a growing body of research. Particularly important are those biomarkers that predict disease ...

Signed new strategic partnerships to accelerate Rockley’s development of real-time, non-invasive biomarker sensing across a range of uses, including monitoring health conditions and providing ...

Most immuno-oncology drugs work by altering the tumor microenviro | This webinar covers how recent advances in multiplex ...

Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...

Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...

As the use of engineered cells for the production of numerous research and clinical applications increases, the need to monitor multiple markers representing the stability and quality of the host cell ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Biomarker development is hardly coextensive with drug development, but in every developmental stage—from exploratory research to clinical trial to therapeutic application—there is significant overlap.

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics (NYSE: RKLY), a leading global silicon photonics technology company, today announced that the company has expanded the range of ...